J Thorac Oncol. 2009 Apr;4(4):444-7.

MET pathway as a therapeutic target.

Source

Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois 60637, USA. rsalgia@medicine.bsd.uchicago.edu

Abstract

Dysregulation of mesenchymal-epithelial transition factor receptor tyrosine kinase pathway leads to cell proliferation, protection from apoptosis, angiogenesis, invasion, and metastasis. It can be dysregulated through overexpression, constitutive activation, gene amplification, ligand-dependent activation or mutation. New drugs targeting various mesenchymal-epithelial transition factor pathways are being investigated with promising results.

PMID:: 19333071; [PubMed - indexed for MEDLINE]
PMCID:: PMC2664527

Free PMC Article

Images from this publication.See all images (1) Free text

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Inhibition of HGF/MET as therapy for malignancy. [Expert Opin Ther Targets. 2009]
Review Inhibition of HGF/MET as therapy for malignancy.
Naran S, Zhang X, Hughes SJ. Expert Opin Ther Targets. 2009 May; 13(5):569-81.
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. [Cancer Res. 2009]
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Seiwert TY, Jagadeeswaran R, Faoro L, Janamanchi V, Nallasura V, El Dinali M, Yala S, Kanteti R, Cohen EE, Lingen MW, et al. Cancer Res. 2009 Apr 1; 69(7):3021-31. Epub 2009 Mar 24.
RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival. [Cancer Res. 2004]
RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival.
Shinomiya N, Gao CF, Xie Q, Gustafson M, Waters DJ, Zhang YW, Vande Woude GF. Cancer Res. 2004 Nov 1; 64(21):7962-70.
Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival. [Cancer Res. 2007]
Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival.
Lutterbach B, Zeng Q, Davis LJ, Hatch H, Hang G, Kohl NE, Gibbs JB, Pan BS. Cancer Res. 2007 Mar 1; 67(5):2081-8.
Review MET receptor tyrosine kinase as a therapeutic anticancer target. [Cancer Lett. 2009]
Review MET receptor tyrosine kinase as a therapeutic anticancer target.
Stellrecht CM, Gandhi V. Cancer Lett. 2009 Jul 18; 280(1):1-14. Epub 2008 Dec 18.

See reviews... See all...

Cited by 7 PubMed Central articles

A novel classification of lung cancer into molecular subtypes. [PLoS One. 2012]
A novel classification of lung cancer into molecular subtypes.
West L, Vidwans SJ, Campbell NP, Shrager J, Simon GR, Bueno R, Dennis PA, Otterson GA, Salgia R. PLoS One. 2012; 7(2):e31906. Epub 2012 Feb 21.
Ancillary testing in lung cancer diagnosis. [Pulm Med. 2012]
Ancillary testing in lung cancer diagnosis.
Dubinski W, Leighl NB, Tsao MS, Hwang DM. Pulm Med. 2012; 2012:249082. Epub 2012 Jan 4.
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database. [J Clin Bioinforma. 2011]
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.
Surati M, Robinson M, Nandi S, Faoro L, Demchuk C, Rolle CE, Kanteti R, Ferguson BD, Hasina R, Gangadhar TC, et al. J Clin Bioinforma. 2011 Feb 28; 1(8):1-11.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

MET pathway as a therapeutic target.
MET pathway as a therapeutic target.
J Thorac Oncol. 2009 Apr ;4(4):444-7.

PubMed
Safety and usefulness of intravenous iron sucrose in the management of preoperat...
Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study.
Acta Haematol. 2009 ;121(1):37-41. Epub 2009 Mar 31 .

PubMed
Morphological evaluation of cystitis glandularis.
Morphological evaluation of cystitis glandularis.
Indian J Pathol Microbiol. 2009 Apr-Jun ;52(2):203-5.

PubMed
Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affec...
Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affective disorder.
Brain Res. 1991 Jul 12 ;553(2):323-6.

PubMed
Prevention of foodborne listeriosis.
Prevention of foodborne listeriosis.
Indian J Pathol Microbiol. 2009 Apr-Jun ;52(2):145-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

MET pathway as a therapeutic target.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 7 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information